<bill session="109" type="s" number="96" updated="2019-11-15T21:52:26Z">
  <state datetime="2005-01-24">REFERRED</state>
  <status>
    <introduced datetime="2005-01-24"/>
  </status>
  <introduced datetime="2005-01-24"/>
  <titles>
    <title type="short" as="introduced">Flu Vaccine Incentive Act of 2005</title>
    <title type="short" as="introduced">FLU-VIA</title>
    <title type="display">Flu Vaccine Incentive Act of 2005</title>
    <title type="official" as="introduced">A bill to target Federal funding for research and development, to amend section 1928 of the Social Security Act to encourage the production of influenza vaccines by eliminating the price cap applicable to the purchase of such vaccines under contracts entered into by the Secretary of Health and Human Services, to amend the Internal Revenue Code of 1986 to establish a tax credit to encourage vaccine production capacity, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="I000024"/>
  <cosponsors/>
  <actions>
    <action datetime="2005-01-24">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2005-01-24">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S261-262"/>
    </action>
    <action datetime="2005-01-24" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
    <action datetime="2006-04-04">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S2844-2845"/>
    </action>
    <action datetime="2006-07-20">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S8051"/>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Child health"/>
    <term name="Commerce"/>
    <term name="Construction costs"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug industry"/>
    <term name="Economics and Public Finance"/>
    <term name="Families"/>
    <term name="Federal aid to research"/>
    <term name="Government Operations and Politics"/>
    <term name="Income tax"/>
    <term name="Industrial buildings"/>
    <term name="Influenza"/>
    <term name="Investment tax credit"/>
    <term name="Medicaid"/>
    <term name="National Institutes of Health (NIH)"/>
    <term name="Pharmaceutical research"/>
    <term name="Prices"/>
    <term name="Research centers"/>
    <term name="Science, Technology, Communications"/>
    <term name="Social Welfare"/>
    <term name="Taxation"/>
    <term name="Technological innovations"/>
    <term name="Vaccines"/>
  </subjects>
  <amendments/>
  <summary date="2005-02-05T16:33:48Z" status="Introduced in Senate">Flu Vaccine Incentive Act of 2005 or FLU-VIA - Rescinds the authority of the Secretary of Health and Human Services under the Consolidated Appropriations Act, 2005, to make certain purchases of inflluenza vaccine.

Amends title XIX (Medicaid) of the Social Security Act to exempt contracts entered into by the Secretary for the purchase of a pediatric influenza vaccine and other vaccines from certain price restrictions otherwise applicable to such contracts. Extends such exemption to any other Federal agency that purchases an influenza vaccine.

Amends the Internal Revenue Code to allow a tax credit for investment in influenza vaccine manufacturing facilities.</summary>
</bill>
